Pharma
Emerging Insights in Healthcare & Pharmaceutical Industries
In January 2023, we were joined by Forrester to explore the most pressing consumer healthcare trends, and the role that insights management plays in helping healthcare and pharmaceutical enterprises stay ahead of the competition. Key takeaways:
Read more3 strategies healthcare companies should adopt right now in their insights teams
If you’re an insights professional in the pharmaceuticals and healthcare industry, your stakeholders (and your stakeholders’ stakeholders – doctors, nurses, health care assistants, patients –) are very tired. But even after years of unprecedented change, the demand for faster, more efficient output continues to increase. This means it’s more important for insights functions in the…
Read moreBalancing efficiency and compliance in the pharmaceutical industry
The Pharmaceutical Industry is home to some of the most far-reaching requirements for market research within modern business. From certain vantage points, the industry seems slow-moving; drug development can take several years (if not decades), with the time between NME declaration and launch averaging 10-12 years. Getting a drug to market means navigating a maze…
Read moreHealthcare and life science trends in a post-Corona world
“There are decades where nothing happens and there are weeks where decades happen.” – Vladimir Lenin During our Virtual Healthcare and Life Sciences Insights Executives Roundtable, we heard from Henry Mason, Evangelist-at-Large at TrendWatching, who noted that every single business has been forced to pivot during these tumultuous times, and entire industries are being shaken…
Read moreThe importance of sharing insights and intelligence during a pandemic
What does it mean to bring insights to life, especially during a pandemic? Hear from pharmaceutical industry experts on how sharing insights and intelligence can drive creativity, storytelling and cross-team collaboration – even in unprecedented circumstances.
Read more“Science will prevail” – the pivots and pauses of pharma during a pandemic
At the first-ever Market Logic virtual insights executive roundtable, we were joined by insights executives and thought leaders from Abbott, Bayer, Bristol-Myers Squibb and Johnson&Johnson. Among other exciting topics, they shared how their insights communities are adapting to the COVID-19 pandemic. Here’s what we heard. First do no harm: patients and doctors come first Every…
Read more